the appeal proceedings between 10X Genomics and NanoString. The court’s local division in Munich had heard the preliminary injunction dispute in December. NanoString informed JUVE Patent that the UPC
, with Carpmaels & Ransford instead taking over the defence. The case marks the first time that a UK law firm will conduct UPC proceedings completely independently. At the Unified Patent Court, US-based
The UPC Munich local division issued a clear injunction in the dispute between two companies from the plant protection industry and upheld the patent. The judges also commented on the two-month
The settlement had been hinted at in recent days after signs emerged in the US and at the UPC that hearings were no longer taking place. JUVE Patent learned from lawyers involved in the case that the
(Amgen first sued Sanofi and Regeneron in the U.S. in 2014). In another recent prong of the dispute, Sanofi sued Amgen in the Unified Patent Court’s (UPC) Dusseldorf Local Division (LD) over the
Roche Diagnostics has now resolved its UPC dispute with Tandem Diabetes Care, VitalAire and other defendants with a settlement. The case was playing out in Hamburg, Düsseldorf and Paris. Since late
So far Dish has been unsuccessful in its international dispute with Aylo over streaming technology. One of the two patents-in-suit was recently revoked in the first instance by both the UPC and the
Context: 10x Genomics was an “early adopter” of the United Patent Court (UPC) with its patent enforcement against NanoString. That dispute has meanwhile been settled on terms presumably favorable to
The UK government has prepared legislation to give effect to EU legislation on the unitary patent and to the Agreement on the Unified Patent Court (UPC), which backs the creation of a new UPC for
requesting a Europe-wide injunction from the UPC. The company is presumably taking into account its action at the UK High Court in London. New claims in London Last November, in response to the first US